BioSpace News Archive

Salarius Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other cancers, announced that David Arthur, CEO of Salarius Pharmaceuticals, will deliver a virtual presentation at the 2022 BIO CEO & Investor Conference.

Akero Therapeutics, Inc. today announced that it has completed enrollment of the Phase 2b HARMONY study of efruxifermin (EFX), a novel FGF21 analog, for the treatment of non-alcoholic steatohepatitis (NASH).

Seagen Inc. announced that management will participate in a virtual fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 2:20 p.m. Eastern Time.

Cerus Corporation (Nasdaq: CERS) announced today that its fourth quarter and full-year 2021 financial results will be released on Tuesday, February 22, 2022, after the close of the stock market.

Aphios Corporation announced today that it has been granted US Patent No. 11,234,932 for treating HIV latency towards an HIV cure.

Seno Medical’s Imagio® Breast Imaging System has been named a finalist in the 2022 Edison Awards competition in the Science and Medical category and Diagnostics sub-category.

Qurient Co. Ltd. (KRX: 115180), a clinical stage biotech company, today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for Q901, a small molecule oncology drug candidate targeting cyclin dependent kinase 7 (CDK7).

The Company is pursuing a well-known and proven to be effective strategy of redeveloping existing and approved drugs to target new indications and diseases.

Texas Medical Center Innovation (TMCi) today announced the 2022 Accelerator for Cancer Therapeutics annual cohort, comprised of Texas-based startups working to address the world’s most significant cancer challenges with novel technologies and treatments.

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2022 on Tuesday, February 22, 2022.